Clarkston Consulting https://www.facebook.com/ClarkstonConsulting https://twitter.com/Clarkston_Inc https://www.linkedin.com/company/clarkston-consulting http://plus.google.com/112636148091952451172 https://www.youtube.com/user/ClarkstonInc
Skip to content

Generics Consulting

Clarkston’s generics consultants help our clients develop and activate strategies to address their specific challenges and emerging trends to drive business.

Contact Our Generics Consulting Team

Industry Challenges

Our generics consulting team is prepared to help your company face some of today’s most pressing challenges.

Speed to Market

The ability to quickly bring a generic drug to market is paramount in the generics industry. Requiring a complex orchestration of multiple internal and external stakeholders, this brings with it a cascading array of potential challenges.

Pricing Challenges Remain

Steadily increasing competition and fluctuating demand has created a significant pricing challenge for the industry. Regulations across the U.S. and globe have already been enacted or drafted in an effort to manage drug pricing through government intervention.

Supply Chain Issues

Access to raw ingredients and API has waned considerably following the onset of the global COVID-19 pandemic, creating significant supply pressures on generic drug makers. Furthermore, changes to patient behavior have also led to fluctuations in demand.

 

The Mandate for Digital

As patients and providers move more and more interactions to the digital landscape, generics makers must adopt new strategies for sales, patient and provider engagement, education, and more.

Addressing Counterfeiting

Though regulations are in place to address the issue, counterfeiting remains a substantial threat to generic drugmakers in terms of patient safety, brand protection, and revenue.

CASE STUDY

Generic Pharmaceutical Manufacturer

 

Patient Centricity Assessment and Strategy

Increased awareness, commitment to, and common language around patient centricity across the specialty marketing organization team and leadership

Activities outlined will grow patient centricity at the organization from Level 2 to Level 4 on the Patient Centricity Maturity Model

Brand planning materials now include >500% additional mentions, interactions, and approaches to include patient-centric thinking into key planning elements

Download the Case Study

Contact Clarkston To Learn More About Our Generics Consulting Practice

Contact Clarkston To Learn More About Our Generics Consulting Practice

  • Clarkston Consulting requests your contact information so we may accurately and effectively respond to your request, as well as share our research and content with you. To learn more, please visit our Privacy Policy.
  • This field is for validation purposes and should be left unchanged.